ALNOV:EPA
Novacyt SA
€0.43
arrow_upward
+1.66%(+0.0070) 1D
Nov 10, 5:35:24 PM GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALNOV...
Open
€0.42
High
€0.43
Low
€0.42
Mkt. cap
32.23M
Avg. vol.
173.25K
Volume
81.77K
52-wk high
€1.04
52-wk low
€0.29
EPS
-€0.38
Shares outstanding
72.59M
No. of employees
228
Open
€0.42
High
€0.43
Low
€0.42
Mkt. cap
32.23M
Avg. vol.
173.25K
Volume
81.77K
52-wk high
€1.04
52-wk low
€0.29
EPS
-€0.38
Shares outstanding
72.59M
No. of employees
228
News stories
From web sources and news partners
RealMoney Pro
·
58 minutes ago
‘Sell in May’ Might Have Been the Right Move This Year
Yahoo Finance
·
2 hours ago
Only 2 Novembers Since 1950 Have Started Worse for the S&P 500 Than This One. Here's What Followed the Other Weak Starts.
www.tmgm.com
·
8 hours ago
Can Dow Jones Futures Extend Gains as Inflation Data and Tech Earnings Come into Focus?
شبكة تواصل الإخبارية
·
1 hour ago
Why this top Wall Street strategist isn't bullish on the S&P 500 for 2027
Profile
Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France. The company produces in vitro and molecular diagnostic tests, supplying assays and reagents worldwide. Its business units include Primerdesign, Microgen Bioproducts and Lab21 Healthcare.
In January 2020 the company announced that its molecular diagnostics division, Primerdesign, had launched a molecular test for the 2019 strain of SARSr-CoV. The test was approved as eligible for procurement under the World Health Organization's Emergency Use Listing process in April 2020, meaning that the test could be supplied by the United Nations and other procurement agencies supporting the COVID-19 response. In the same month Novacyt announced a collaboration with AstraZeneca, GlaxoSmithKline and the University of Cambridge to support the UK in its COVID-19 national screening programme at a new testing laboratory at the university's Anne McLaren laboratory. Wikipedia
About Novacyt SA
CEODavid Allmond
Employees228
FoundedJul 3, 2006
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitenovacyt.com